A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality
2 other identifiers
observational
40
0 countries
N/A
Brief Summary
The current study combines a molecular genetic perspective, self report and brain imaging to the study of human sexuality in control subjects and individuals from a sexual disorder clinic. The investigators hypothesize that the variability in components of the brain dopaminergic system expressed in the mesolimbic reward system can explain variability in human sexuality, especially in desire and pleasure associated with sex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2011
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2007
CompletedFirst Posted
Study publicly available on registry
December 7, 2007
CompletedStudy Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedJune 10, 2010
June 1, 2010
6 months
December 6, 2007
June 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brain Imaging data of DRD2 receptor occupancy during watching a sex videotape and neutral videotape
2 Brain imaging sessions a week apart
Secondary Outcomes (1)
Questionnaire ratings of human sexuality, pleasure, and anticipatory reward
Taken during brain scans
Study Arms (2)
1
Healthy control subjects (n=20) age 21-65 who do not suffer from a psychiatric diagnosis or neurological damage, are under age, or are pregnant women
2
20 patients who suffer from sexual disorder (reduced sexual desire or sexual function) from a sexual disorder clinic, age 21-65, without any other psychiatric disorder, neurological damage, are not under age or pregnant women.
Eligibility Criteria
A group of healthy volunteers from the general public. A group of patients who suffer from sexual disorder from a primary care clinic.
You may qualify if:
- Healthy volunteers and patients
- Age 21-65
- Male or female
You may not qualify if:
- Psychiatric diagnosis/psychosis
- Neurological damage associated with loss of consciousness
- Infectious disease HIV
- Herpes
- Syphilis
- Hyperactivity treated with ritalin
- Pregnant women
- Under age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hadassah Medical Organizationlead
- Ben-Gurion University of the Negevcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aviv M Weinstein, Ph.D
Hadasah Medical Organization, Jerusalem Israel
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 6, 2007
First Posted
December 7, 2007
Study Start
April 1, 2011
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
June 10, 2010
Record last verified: 2010-06